Pursuant to SEBI circular Eiko Lifesciences Ltd is not a Large Corporate. Hence filing of initial and annual disclosure does not arise.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd has informed the BSE that as of March 31, 2025, it does not qualify as a 'Large Corporate' under the criteria laid out in SEBI's November 26, 2018 circular on fund raising via debt securities by large corporates. Because of this, the framework for debt securities issuance by large corporates does not apply to the company. Consequently, the company is not required to submit the initial or annual disclosure that would otherwise be mandatory for large corporates. The letter is signed by Chintan Doshi, Company Secretary and Compliance Officer, and is dated April 16, 2025. This is a routine, compliance-related clarification rather than any business or capital-raising announcement.
No material impact on shareholders or stock price — this is a routine regulatory confirmation that the company falls below the Large Corporate threshold, meaning no additional debt-related disclosure obligations apply at this time.